Back
Pharming Group 10K Form
Sell
22
PHAR
Pharming Group
Last Price:
9.79
Seasonality Move:
-9.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PHAR News And Ratings
See the #1 stock for the next 7 days that we like better than PHAR
PHAR Financial Statistics
Sales & Book Value
| Annual Sales: | $245.32M |
|---|---|
| Cash Flow: | $11.25M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.26 |
| Price / Book: | 2.96 |
Profitability
| EPS (TTM): | -0.16000 |
|---|---|
| Net Income (TTM): | $-10.55M |
| Gross Margin: | $220.1M |
| Return on Equity: | -5.11% |
| Return on Assets: | -2.42% |
Pharming Group Earnings Forecast
Key Pharming Group Financial Ratios
- The Gross Profit Margin over the past 18 years for PHAR is 89.72%.
- The Selling, General & Administrative Expenses for PHAR have been equal to 35.67% of Gross Profit Margin.
- The Research & Development expenses have been 28.09% of Revenue.
- The Interest Expense is -56.54% of Operating Income.
- The Net Earning history of PHAR is -4.30% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 8 years.
Pharming Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PHAR |
| Website: | pharming.com |
Debt
| Debt-to-Equity Ratio: | 0.63 |
|---|---|
| Current Ratio: | 4.06 |
| Quick Ratio: | 3.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 391.84 |
PHAR Technical Analysis vs Fundamental Analysis
Sell
22
Pharming Group (PHAR)
is a Sell
Is Pharming Group a Buy or a Sell?
-
Pharming Group stock is rated a Sell
The current Pharming Group [PHAR] share price is $9.60. The Score for PHAR is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.